News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
TechStock² Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Earlier this month, BioMarin Pharmaceutical reported second-quarter 2026 results showing revenue of US$989.71 million and updated earnings guidance for the second half and full year, including a slight increase in its 2026 revenue outlook to US$3.88 billion–US$3.93 billion. Alongside these results, BioMarin filed a …
* Cue Biopharma press release [https://seekingalpha.com/pr/20620099-cue-biopharma-reports-second-quarter-2026-financial-results-and-recent-business-highlights] (CUE [https://seekingalpha.com/symbol/CUE]): Q2 GAAP EPS of -$24.14 misses by $22.23. * Revenue of $7.88M (+167.1% Y/Y) beats by $5.78M. * As of June 30, 2026, the company had $17.4 million in cash and cash equivalents after incurring one-time …
* Citius Pharmaceuticals press release [https://seekingalpha.com/pr/20620155-citius-pharmaceuticals-inc-reports-fiscal-third-quarter-2026-financial-results-and-provides] (CTXR [https://seekingalpha.com/symbol/CTXR]): Q3 GAAP EPS of -$0.34 misses by $0.09. * Revenue of $1.5M misses by $8.27M. * Cash and cash equivalents of $17.0 million as of June 30, 2026. MORE ON CITIUS PHARMACEUTICALS * Seeking Alpha’s Quant …
* Traws Pharma press release [https://seekingalpha.com/pr/20620150-traws-pharma-reports-q2-2026-financial-results-and-provides-business-highlights] (TRAW [https://seekingalpha.com/symbol/TRAW]): Q2 GAAP EPS of -$0.16 beats by $0.06. * Cash and cash equivalents: As of June 30, 2026, the Company had cash and cash equivalents of $5.0 million, compared to $3.8 million as of December 31, …
The appliance maker’s weekly trend remains active, but the latest return and Relative Strength reading point to a more mixed setup.
Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Recent coverage of Clean Harbors (CLH) has focused on its 13.5% five year compounded annual sales growth and stronger free cash flow margins, which together …
On August 14, Pony.ai (NASDAQ:PONY) said it would deploy more than 2,000 robotaxis across Europe under an expanded partnership with Uber (NYSE:UBER) that dates back to May 2025. The rollout stretches from an existing commercial service in Zagreb, Croatia to four additional European cities, …
Vanda Pharmaceuticals is set to launch BYSANTI in the second half of 2026 following FDA approval for bipolar I disorder and schizophrenia, with patent protection extending until May 2044. The company also reported strong Q2 Fanapt sales growth and has several late-stage pipeline readouts …
Teddy Ray Price, a director at Red River Bancshares Inc. (NASDAQ: RRBI), recently purchased $111,798 worth of the company's common stock, transacting at prices between $99.89 and $101.31 per share. These purchases, made on August 10, 2026, come as RRBI trades near its 52-week …
West Pharmaceutical Services (WST) has seen significant share price appreciation and currently trades at $349.42, with analysts estimating a fair value of around $404, suggesting it is undervalued by approximately 13.5%. The company's growth is driven by GLP-1 exposure and plans for operational efficiencies, …
Bending Spoons S.p.A. (NASDAQ:BSP) just released its first earnings report as a public company, and it was impressive by almost every headline measure. Investors focused on a different number entirely. A Blowout Quarter On August 13, the company released second-quarter 2026 earnings that exceeded …
This article provides a price forecast for WeRide Inc. Sponsored ADR Class A (WRD/N) for 2027, based on analysis from 11 analysts. The current price target is 238.44, with no maximum or minimum estimates provided. The analyst rating is based on 16 analysts' assessments …
SK Hynix (NASDAQ: SKHY) stock enjoyed a strong rally this week, with its share price rising 20.6% across the stretch. The S&P 500 rose 1.2% over the period, and the Nasdaq Composite gained 1.7%. SK Hynix's share price moved higher due to news that …
Tarsus Pharmaceuticals (TARS) saw its stock rise by 6.8% after reporting strong second-quarter 2026 results and raising its 2026 XDEMVY net product sales guidance to US$685 million–US$705 million. This increase signals management's confidence in XDEMVY's commercial trajectory, though the company still faces risks associated …
Quick Read Paying off a mortgage removes principal and interest but leaves property taxes, insurance, and maintenance free to outpace Social Security income. The 2026 COLA of 2.8% adds just $56 a month on a $2,000 benefit, which a single reassessment or insurance hike …
Ascendis Pharma A/S reported strong Q2 results, with revenues beating expectations by 2.8% and statutory profit exceeding forecasts by 104%. Analysts have subsequently upgraded their EPS estimates for 2026, though the consensus price target remains unchanged at US$310. The company is expected to continue …
Bitdeer Technologies Group has liquidated its entire Bitcoin (BTC) holdings, selling all 189.8 BTC mined during the week and its remaining 943.1 BTC reserve, completing an eight-week drawdown. This zero-holdings disclosure followed Bitdeer's announcement of a $300 million convertible note offering and direct equity …
The Rosen Law Firm is encouraging investors of Wise Group plc (NASDAQ: WSE) to secure legal counsel before the September 29, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Wise Group plc made false and misleading statements regarding its …
Private Advisory Group LLC recently acquired a new position in L3Harris Technologies Inc., purchasing 35,408 shares valued at approximately $10.3 million. This comes as institutional investors collectively own a significant 84.76% of the company. L3Harris has shown strong financial performance, exceeding quarterly expectations with …
SCS Capital Management LLC acquired 612,850 shares of Agios Pharmaceuticals (NASDAQ:AGIO) during the second quarter, valued at approximately $22.7 million. The biopharmaceutical company reported a quarterly loss per share of $1.69, missing estimates, but exceeded revenue expectations with $44.75 million. Analyst sentiment for AGIO …
The State of Wyoming acquired 38,495 shares of Harley-Davidson, Inc. (NYSE:HOG) in the second quarter, valued at approximately $942,000. Institutional investors now own 85.10% of the company, and analysts generally maintain a "Hold" rating with an average price target of $26.11. Harley-Davidson recently exceeded …
Find your next quality investment with Simply Wall St's easy and powerful screener, trusted by over 7 million individual investors worldwide. BioMarin Pharmaceutical (BMRN) has just given investors a packed update, including second quarter 2026 results, fresh earnings guidance for the rest of the …
Sharemaestro market context New activity signal 52 weeks +11.9% · Next-week setup negative 4.6%S&CO Inc. has acquired a new position in Linde PLC (NASDAQ:LIN), purchasing 26,139 shares valued at approximately $13.56 million in the second quarter. Other institutional investors have also modified their holdings, with hedge funds and institutional investors collectively owning 82.80% of Linde's stock. Linde …
SFE Investment Counsel has acquired a new stake of $6.91 million in L3Harris Technologies Inc, purchasing 23,782 shares during the second quarter. The company reported strong quarterly earnings of $3.13 per share, exceeding estimates, with an 8.4% rise in revenue. L3Harris also declared a …
USA Financial Formulas has acquired a new stake in Regeneron Pharmaceuticals (NASDAQ:REGN), purchasing 1,457 shares valued at approximately $1.13 million, making it their 27th-largest portfolio holding. Institutional investors collectively own 83.31% of Regeneron, with several major firms significantly increasing their positions. The company recently …
Search by ticker symbol or company name and select a result to open its chart.